161 related articles for article (PubMed ID: 28817437)
21. Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?
Hizal M; Sendur MA; Bilgin B; Bulent Akinci M; Sener Dede D; Yalcin B
J BUON; 2019; 24(4):1367-1370. PubMed ID: 31646779
[TBL] [Abstract][Full Text] [Related]
22. [Adjuvant therapy after curative resection with D2 lymphadenectomy for gastric cancer: results of a prospective clinical trial].
Markelis R; Endzinas Z; Kiudelis M; Grizas S; Pundzius J; Saladzinskas Z; Juozaityte E; Inciūra A; Pranys D; Maleckas A
Medicina (Kaunas); 2009; 45(6):460-8. PubMed ID: 19605966
[TBL] [Abstract][Full Text] [Related]
23. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
24. [Multidisciplinary therapy for 3 patients with lymph node recurrence after curative gastrectomy].
Kawasaki K; Iwasaki Y; Yajima K; Oohinata R; Yuu K; Iwanaga T; Karasawa K; Maeda Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2283-5. PubMed ID: 24394086
[TBL] [Abstract][Full Text] [Related]
25. Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques.
Wu Q; Li G; Xu F
Expert Rev Anticancer Ther; 2015 Jun; 15(6):703-13. PubMed ID: 26004039
[TBL] [Abstract][Full Text] [Related]
26. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
30. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial.
Straatman J; van der Wielen N; Cuesta MA; Gisbertz SS; Hartemink KJ; Alonso Poza A; Weitz J; Mateo Vallejo F; Ahktar K; Diez Del Val I; Roig Garcia J; van der Peet DL
Trials; 2015 Mar; 16():123. PubMed ID: 25873249
[TBL] [Abstract][Full Text] [Related]
31. [Perioperative chemotherapy in gastric cancer treatment - the surgeons view].
Hoskovec D
Cas Lek Cesk; 2014; 153(5):227-30. PubMed ID: 25370767
[TBL] [Abstract][Full Text] [Related]
32. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.
Krijnen P; den Dulk M; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; van de Velde CJ
Eur J Surg Oncol; 2009 Jul; 35(7):715-20. PubMed ID: 19144490
[TBL] [Abstract][Full Text] [Related]
33. A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis.
He Q; Ma L; Li Y; Li G
BMC Gastroenterol; 2016 Jan; 16():8. PubMed ID: 26782354
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
[TBL] [Abstract][Full Text] [Related]
35. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma.
Li Z; Li S; Bu Z; Zhang L; Wu X; Shan F; Jia Y; Ji X; Ji J
J Surg Oncol; 2018 Sep; 118(4):657-663. PubMed ID: 30196579
[TBL] [Abstract][Full Text] [Related]
36. Compliance to D2 lymphadenectomy in laparoscopic gastrectomy.
Eshuis WJ; van Berge Henegouwen MI; Draaisma WA; Gisbertz SS
Updates Surg; 2018 Jun; 70(2):197-205. PubMed ID: 29926307
[TBL] [Abstract][Full Text] [Related]
37. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
39. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
Datta J; McMillan MT; Ruffolo L; Lowenfeld L; Mamtani R; Plastaras JP; Dempsey DT; Karakousis GC; Drebin JA; Fraker DL; Roses RE
Ann Surg Oncol; 2016 Sep; 23(9):2936-45. PubMed ID: 27090793
[TBL] [Abstract][Full Text] [Related]
40. A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection.
Wang X; Shen Y; Zhu H; Zhao Y; Li Z; Qiu M; Li Q; Gou H; Yang Y; Cao D; Liu J; Yi C; Liao Z; Luo D; Bi F; Xu F
Gastric Cancer; 2016 Jan; 19(1):245-54. PubMed ID: 25609451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
